NYSE:WST

West Pharmaceutical Services - WST Stock Forecast, Price & News

$321.79

-6.46 (-1.97%)

(As of 08/18/2022 05:17 PM ET)

Add

Compare

Today's Range: $320.95
▼
$328.63
50-Day Range: $280.61
▼
$343.65
52-Week Range: $275.89
▼
$475.35

Volume: 381,889 shs
Average Volume: 431,939 shs
Market Capitalization: $23.83 billion

P/E Ratio: 35.71
Dividend Yield: 0.22%
Price Target: N/A

West Pharmaceutical Services MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
1.24% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -2.53
Upright™ Environmental Score
News Sentiment: 0.25
Based on 9 Articles This Week
Insider Trading: Selling Shares
$1.85 M Sold Last Quarter
Proj. Earnings Growth: 7.78%
From $9.13 to $9.84 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.98 out of 5 stars

Medical Sector

34th out of 1,119 stocks

Fabricated Rubber Products, Not Elsewhere Classified Industry

1st out of 2 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for West Pharmaceutical Services.

5.0

Short Interest

Percentage of Shares Shorted
1.24% of the float of West Pharmaceutical Services has been sold short.
Short Interest Ratio / Days to Cover
West Pharmaceutical Services has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in West Pharmaceutical Services has recently decreased by 5.07%, indicating that investor sentiment is improving significantly.

3.3

Dividend Strength

Dividend Yield
West Pharmaceutical Services has a dividend yield of 0.22%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
West Pharmaceutical Services has been increasing its dividend for 29 years.
Dividend Coverage
The dividend payout ratio of West Pharmaceutical Services is 7.99%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 7.32% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.

3.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
West Pharmaceutical Services has received a 33.75% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Plastic medicine bottles", "Plastic medicine vials", and "Pen needles" products. See details.
Environmental Sustainability
The Environmental Impact score for West Pharmaceutical Services is -2.53.

1.8

News and Social Media Coverage

News Sentiment
West Pharmaceutical Services has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 9 news articles for West Pharmaceutical Services this week, compared to 4 articles on an average week.
Search Interest
Only 3 people have searched for WST on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added West Pharmaceutical Services to their MarketBeat watchlist in the last 30 days. This is a decrease of -63% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, West Pharmaceutical Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,848,280.00 in company stock.
Percentage Held by Insiders
Only 0.60% of the stock of West Pharmaceutical Services is held by insiders.
Percentage Held by Institutions
93.25% of the stock of West Pharmaceutical Services is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for West Pharmaceutical Services are expected to grow by 7.78% in the coming year, from $9.13 to $9.84 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of West Pharmaceutical Services is 35.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 124.46.
Price to Earnings Ratio vs. Sector
The P/E ratio of West Pharmaceutical Services is 35.67, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 94.37.
Price to Earnings Growth Ratio
West Pharmaceutical Services has a PEG Ratio of 1.34. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
West Pharmaceutical Services has a P/B Ratio of 9.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About West Pharmaceutical Services (NYSE:WST) Stock

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

West Pharmaceutical Services Trading Down 1.7 %

NYSE:WST opened at $328.25 on Thursday. West Pharmaceutical Services has a 1-year low of $275.89 and a 1-year high of $475.35. The business's 50-day moving average price is $312.30 and its two-hundred day moving average price is $345.22. The company has a current ratio of 3.13, a quick ratio of 2.41 and a debt-to-equity ratio of 0.09. The firm has a market capitalization of $24.31 billion, a price-to-earnings ratio of 36.43, a PEG ratio of 1.34 and a beta of 1.15.

West Pharmaceutical Services (NYSE:WST - Get Rating) last released its earnings results on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share for the quarter, beating the consensus estimate of $2.19 by $0.28. West Pharmaceutical Services had a return on equity of 29.08% and a net margin of 23.41%. The firm had revenue of $771.30 million for the quarter, compared to analyst estimates of $754.25 million. During the same quarter in the prior year, the firm posted $2.46 earnings per share. The company's quarterly revenue was up 6.6% on a year-over-year basis. On average, equities analysts expect that West Pharmaceutical Services will post 9.13 earnings per share for the current year.

Analyst Ratings Changes

Separately, StockNews.com cut West Pharmaceutical Services from a "buy" rating to a "hold" rating in a report on Thursday, April 28th.

Insider Buying and Selling at West Pharmaceutical Services

In other West Pharmaceutical Services news, insider Silji Abraham sold 5,374 shares of the stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $343.93, for a total value of $1,848,279.82. Following the transaction, the insider now owns 3,201 shares of the company's stock, valued at $1,100,919.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.60% of the company's stock.

Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

WST Stock News Headlines

August 16, 2022 | finance.yahoo.com

West Pharmaceutical's (WST) Latest Investment to Boost Business

August 11, 2022 | finance.yahoo.com

West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms

August 9, 2022 | nasdaq.com

West Pharmaceutical Services, Inc. (NYSE:WST) insiders sold US$6.7m worth of stock, possibly signalling a downtrend

August 6, 2022 | americanbankingnews.com

West Pharmaceutical Services, Inc. (NYSE:WST) Insider Silji Abraham Sells 5,374 Shares

August 5, 2022 | msn.com

Here's How Much $1000 Invested In West Pharmaceutical Servs 10 Years Ago Would Be Worth Today

August 3, 2022 | americanbankingnews.com

Jefferies Financial Group Analysts Decrease Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)

August 2, 2022 | americanbankingnews.com

FY2022 Earnings Forecast for West Pharmaceutical Services, Inc. (NYSE:WST) Issued By William Blair

August 2, 2022 | americanbankingnews.com

Q3 2022 EPS Estimates for West Pharmaceutical Services, Inc. Decreased by Analyst (NYSE:WST)

August 1, 2022 | finance.yahoo.com

Here's Why We Think West Pharmaceutical Services (NYSE:WST) Is Well Worth Watching

July 28, 2022 | finance.yahoo.com

West Pharmaceutical Services (WST) Q2 2022 Earnings Call Transcript

July 28, 2022 | seekingalpha.com

West Pharmaceutical Services, Inc.'s (WST) CEO Eric Green on Q2 2022 Results - Earnings Call Transcript

July 28, 2022 | finance.yahoo.com

West Pharmaceutical Services (WST) Q2 Earnings and Revenues Surpass Estimates

July 28, 2022 | finance.yahoo.com

West Pharmaceutical (WST) Q2 Earnings Beat, FY22 View Cut

July 12, 2022 | finance.yahoo.com

West Pharmaceutical Services Releases 2021 Corporate Responsibility Report

July 6, 2022 | marketwatch.com

West Pharmaceutical Services Inc. stock rises Wednesday, outperforms market

July 6, 2022 | seekingalpha.com

West Pharmaceutical Services: A Great Business At A Lofty Price

July 5, 2022 | morningstar.com

West Pharmaceutical Services Inc - Stock Trailing Returns WST

June 23, 2022 | finance.yahoo.com

Is Weakness In West Pharmaceutical Services, Inc. (NYSE:WST) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

June 16, 2022 | finance.yahoo.com

West Pharmaceutical's (WST) Syringe System to Improve Outcome

June 13, 2022 | finance.yahoo.com

West Introduces Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System at BIO International Convention

June 10, 2022 | nasdaq.com

S&P 500 Analyst Moves: WST

May 24, 2022 | nasdaq.com

West Pharmaceutical Services is Oversold

May 24, 2022 | finance.yahoo.com

Those who invested in West Pharmaceutical Services (NYSE:WST) five years ago are up 219%

May 23, 2022 | nasdaq.com

Here's Why West Pharmaceutical Services (WST) is a Strong Growth Stock

May 23, 2022 | finance.yahoo.com

West to Attend and Showcase Industry Leadership in Packaging and Containment at INTERPHEX 2022

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

WST Company Calendar

Ex-Dividend for 8/3 Dividend: 7/19/2022
Last Earnings: 7/28/2022
Dividend Payable: 8/03/2022
Today: 8/18/2022
Next Earnings (Estimated): 10/27/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Fabricated rubber products, not elsewhere classified
Sub-Industry: Health Care Supplies
Sector: Medical
Current Symbol: NYSE:WST
CUSIP: 95530610
CIK: 105770
Web: www.westpharma.com
Phone: (610) 594-2900
Fax: 800-345-9800
Employees: 10,065
Year Founded: 1923

Profitability

EPS (Most Recent Fiscal Year): $9.01
Trailing P/E Ratio: 35.71
Forward P/E Ratio: 35.25
P/E Growth: 1.34
Net Income: $661.80 million
Net Margins: 23.41%
Pretax Margin: 26.57%
Return on Equity: 29.08%
Return on Assets: 20.60%

Debt

Debt-to-Equity Ratio: 0.09
Current Ratio: 3.13
Quick Ratio: 2.41

Sales & Book Value

Annual Sales: $2.83 billion
Price / Sales: 8.41
Cash Flow: $10.09 per share
Price / Cash Flow: 31.90
Book Value: $32.74 per share
Price / Book: 9.83

Miscellaneous

Outstanding Shares: 74,048,000
Free Float: 73,604,000
Market Cap: $23.83 billion
Optionable: Optionable
Beta: 1.15

Social Links

Key Executives

Mr. Eric M. Green (Age 52)
Chair, Pres & CEO
Comp: $3.42M

Mr. Bernard J. Birkett (Age 53)
Sr. VP and Chief Financial & Operations Officer
Comp: $1.5M

Mr. Silji Abraham (Age 50)
Sr. VP & Chief Technology Officer
Comp: $1.11M

Ms. Kimberly Banks MacKay (Age 56)
Sr. VP, Gen. Counsel & Company Sec.
Comp: $946.43k

Mr. Chad R. Winters (Age 43)
VP, Chief Accounting Officer & Corp. Controller

Dr. Quintin J. Lai C.F.A. (Age 55)
Ph.D., VP of Strategy & Investor Relations

Michele Polinsky
VP of Global Communications

Mr. Robert Segura
VP of Corp. Devel.

Ms. Annette F. Favorite (Age 57)
Chief HR Officer & Sr. VP

Mr. Richard D. Luzzi (Age 70)
Sr. VP of HR

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

WST Stock - Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" WST shares.
View WST analyst ratings or view top-rated stocks.
How have WST shares performed in 2022?: West Pharmaceutical Services' stock was trading at $469.01 at the beginning of the year. Since then, WST stock has decreased by 30.0% and is now trading at $328.25.
View the best growth stocks for 2022 here.
When is West Pharmaceutical Services' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our WST earnings forecast.
How were West Pharmaceutical Services' earnings last quarter?: West Pharmaceutical Services, Inc. (NYSE:WST) issued its earnings results on Thursday, July, 28th. The medical instruments supplier reported $2.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.19 by $0.28. The medical instruments supplier earned $771.30 million during the quarter, compared to the consensus estimate of $754.25 million. West Pharmaceutical Services had a net margin of 23.41% and a trailing twelve-month return on equity of 29.08%. The company's quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.46 EPS.
Read the conference call transcript.
How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?: West Pharmaceutical Services announced a quarterly dividend on Thursday, April 28th. Investors of record on Wednesday, July 20th will be given a dividend of $0.18 per share on Wednesday, August 3rd. This represents a $0.72 annualized dividend and a dividend yield of 0.22%. The ex-dividend date is Tuesday, July 19th.
Read our dividend analysis for WST.
Is West Pharmaceutical Services a good dividend stock?: West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.72 per share and currently has a dividend yield of 0.22%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 7.99%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 7.32% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.
What guidance has West Pharmaceutical Services issued on next quarter's earnings?: West Pharmaceutical Services issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $9.00-$9.15 for the period, compared to the consensus EPS estimate of $9.32. The company issued revenue guidance of $2.95 billion-$2.98 billion, compared to the consensus revenue estimate of $3.05 billion.
What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?: 107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?: Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).
What is West Pharmaceutical Services' stock symbol?: West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."
Who are West Pharmaceutical Services' major shareholders?: West Pharmaceutical Services' stock is owned by a number of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (8.44%), State Street Corp (4.49%), Franklin Resources Inc. (3.74%), FMR LLC (2.75%), WCM Investment Management LLC (1.49%) and Brown Advisory Inc. (1.46%). Insiders that own company stock include Annette F Favorite, David A Montecalvo, George Lloyd Miller, Patrick J Zenner, Quintin J Lai and Silji Abraham.
View institutional ownership trends.
How do I buy shares of West Pharmaceutical Services?: Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is West Pharmaceutical Services' stock price today?: One share of WST stock can currently be purchased for approximately $328.25.
How much money does West Pharmaceutical Services make?: West Pharmaceutical Services (NYSE:WST) has a market capitalization of $24.31 billion and generates $2.83 billion in revenue each year. The medical instruments supplier earns $661.80 million in net income (profit) each year or $9.01 on an earnings per share basis.
How many employees does West Pharmaceutical Services have?: The company employs 10,065 workers across the globe.
Does West Pharmaceutical Services have any subsidiaries?: The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More
When was West Pharmaceutical Services founded?: West Pharmaceutical Services was founded in 1923.
How can I contact West Pharmaceutical Services?: West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The official website for the company is www.westpharma.com. The medical instruments supplier can be reached via phone at (610) 594-2900, via email at quintin.lai@westpharma.com, or via fax at 800-345-9800.

This page (NYSE:WST) was last updated on 8/18/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

West Pharmaceutical Services - WST Stock Forecast, Price & News

West Pharmaceutical Services MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About West Pharmaceutical Services (NYSE:WST) Stock

West Pharmaceutical Services Trading Down 1.7 %

Analyst Ratings Changes

Insider Buying and Selling at West Pharmaceutical Services

WST Stock News Headlines

WST Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

WST Stock - Frequently Asked Questions

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™